sellWeak cluster of 2

Brian Savage sold $285k of TEVA

Interim Chief Legal Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD. 7,342 shares at an average of $38.85, traded Sep 18, 2026, filed Sep 22, 2026.

Warning score

Value

$285k

7,342 shares

Holdings after

8,500

-46% from before

From 52-week low

+113%

low $18.34, close $38.98

From 52-week high

-1%

high $39.25, as of Sep 18, 2026

Score components

Role
Officer
+15
Trade size
$285k at market
+14
Share of holdings sold
Sold 46% of holdings
+10
Cluster
2 insiders selling within 14 days
+8
Exercise and sell
Shares came from an option exercise in the same filing
-15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

TEVAOct 9, 2026 · close 41.10

Since filing Sep 22, 2026: +4.0%SPY +0.7% · excess +3.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-398105, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Sep 18, 2026	MOption exercise Ordinary Shares	+4,503	$34.70	$156k	15,842	19 d ago
Sep 18, 2026	SOpen-market sale Ordinary Shares	-4,503	$38.69	$174k	11,339	19 d ago
Sep 18, 2026	SOpen-market sale Ordinary Shares	-2,525	$39.15	$99k	8,814	19 d ago
Sep 18, 2026	SOpen-market sale Ordinary Shares	-314	$38.70	$12k	8,500	19 d ago
Sep 18, 2026	MOption exercise Stock Options (right to buy)derivative	-4,503	$34.70	$156k	0	19 d ago

Related signals

Other insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
68Notable	TEVAsell 2 TEVA PHARMACEUTICAL INDUSTRIES LTD	Roberto Mignone director	$14M 367,600 shares	-100%	19 d ago
40Moderate	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Richard Daniell Exec. VP, European Commercial	$1.1M 70,961 shares	-59%	Mar 7, 2025
40Moderate	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Richard Daniell Exec. VP, European Commercial	$2.2M 140,372 shares	-419%	Mar 6, 2025
5Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Christine Fox EVP, Head of U.S. Commercial	$98k 6,181 shares	-10%	Mar 6, 2025
21Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Richard D Francis President and CEO	$376k 23,773 shares	-8%	Mar 6, 2025
30Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Eric A Hughes See "Remarks"	$367k 23,251 shares	-100%	Mar 6, 2025
40Moderate	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Richard Daniell Exec. VP, European Commercial	$999k 62,250 shares	-100%	Mar 5, 2025
28Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Richard D Francis President and CEO	$503k 31,342 shares	-11%	Mar 5, 2025
31Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Eric A Hughes See "Remarks"	$400k 24,900 shares	-100%	Mar 5, 2025
36Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	Eliyahu Sharon Kalif EVP, Chief Financial Officer	$903k 55,750 shares	-27%	Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.